ZIM Laboratories Limited (BOM:541400)

ZIM Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	46.3	19.47	96	64.21	34.2	13.93
Short-Term Investments	-	0.9	2.84	-	-	-
Cash & Short-Term Investments	46.3	20.37	98.84	64.21	34.2	13.93
Cash Growth	-20.38%	-79.40%	53.95%	87.72%	145.62%	-4.69%
Accounts Receivable	1,021	1,069	1,035	987.12	977.47	816.55
Other Receivables	-	0.76	0.34	0.28	0.39	1.45
Receivables	1,021	1,070	1,035	987.4	978.08	818.82
Inventory	955.87	864.7	812.63	537.06	752.84	543.47
Prepaid Expenses	-	24.01	18.3	17.55	9.81	14.04
Other Current Assets	245.24	334.04	311.49	303.27	346.43	527.35
Total Current Assets	2,268	2,313	2,276	1,909	2,121	1,918
Property, Plant & Equipment	1,973	2,024	1,804	1,216	1,069	1,052
Long-Term Investments	0.5	0.5	0.52	0.52	0.52	0.52
Goodwill	1.69	1.69	1.69	1.69	1.69	1.69
Other Intangible Assets	359.11	321.74	224.9	139.21	103.49	117.96
Long-Term Deferred Tax Assets	-	-	-	-	-	26.06
Other Long-Term Assets	99.04	59.25	160.13	149.3	120.57	131.61
Total Assets	4,701	4,720	4,468	3,416	3,416	3,248
Accounts Payable	615.85	695.06	623.81	582.39	810.71	648.71
Accrued Expenses	5.31	101.38	78.83	83.93	51.18	64.7
Short-Term Debt	-	524.61	550.4	228.8	173.45	446.31
Current Portion of Long-Term Debt	705.81	194.04	157.12	120.63	150.4	146.41
Current Portion of Leases	41.76	35.64	24.72	15.72	14.07	10.82
Current Income Taxes Payable	8.55	29.2	-	-	20.66	-
Current Unearned Revenue	-	3.85	4.88	3.66	4.48	5.3
Other Current Liabilities	225.33	79.86	154.5	72.74	234.17	98.12
Total Current Liabilities	1,603	1,664	1,594	1,108	1,459	1,420
Long-Term Debt	467.24	403.01	356.01	246.25	189.23	218.29
Long-Term Leases	14.68	20.7	29.5	10.18	7.22	1.68
Long-Term Deferred Tax Liabilities	103.55	110.5	101.01	48.03	3.63	-
Total Liabilities	2,188	2,198	2,081	1,412	1,659	1,640
Common Stock	487.36	487.26	487.26	487.26	162.42	162.42
Additional Paid-In Capital	-	80.3	80.3	80.3	409.89	409.89
Retained Earnings	-	1,701	1,585	1,416	1,177	1,031
Comprehensive Income & Other	2,026	253.62	234.97	19.61	8.23	4.59
Total Common Equity	2,513	2,522	2,387	2,003	1,757	1,608
Minority Interest	0.01	0.01	0	-	-	-
Shareholders' Equity	2,513	2,522	2,387	2,003	1,757	1,608
Total Liabilities & Equity	4,701	4,720	4,468	3,416	3,416	3,248
Total Debt	1,229	1,178	1,118	621.58	534.37	823.51
Net Cash (Debt)	-1,183	-1,158	-1,019	-557.38	-500.17	-809.58
Net Cash Per Share	-24.29	-23.76	-20.91	-11.44	-10.26	-16.63
Filing Date Shares Outstanding	47.18	48.73	48.73	48.73	48.73	48.73
Total Common Shares Outstanding	47.18	48.73	48.73	48.73	48.73	48.73
Working Capital	665.63	649.43	682.23	801.61	662.27	497.25
Book Value Per Share	53.27	51.77	49.00	41.12	36.06	32.99
Tangible Book Value	2,153	2,199	2,161	1,863	1,652	1,488
Tangible Book Value Per Share	45.63	45.13	44.35	38.23	33.90	30.54
Land	-	96.16	96.16	96.16	96.16	96.16
Buildings	-	819.87	790.03	503.21	471.4	436.39
Machinery	-	1,364	1,338	1,018	943.73	872.98
Construction In Progress	-	440.54	235.16	178.39	50.97	45.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.